Less than one in five Novo Nordisk execs is a woman – chairman expects change over time
The very top of the Danish drugmaker has only grown more distant to its own goal of ensuring 45% male/female representation across leadership teams.
by stine løcke nielsen & christopher due karlsson, translated by daniel pedersen
Novo Nordisk is quick to boast of its big focus on diversity, and Thursday’s general annual meeting at the Bella Center Copenhagen was no exception.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Nordisk executive resigns
For subscribers
Leo Pharma's board still struggles with skewed gender ratio
For subscribers
EU agrees on approach to gender equality directive
For subscribers
